SARS-CoV-2 vaccine-induced immune responses and breakthrough infections in people with multiple sclerosis treated with ocrelizumab (OCR)
MULTIPLE SCLEROSIS JOURNAL(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL(2022)